Deadline: 23-Oct-24
Pfizer’s Quality Improvement Competitive Grant Program seeks projects that will address quality gaps in headache medicine, support tools and interventions that can lead to measurable improvements in healthcare services for migraine patients.
Project Types and Area of Interest
- Projects to identify and address the needs, barriers and gaps in migraine management are eligible for support, including but not limited to:
- Needs assessment to better understand and identify knowledge gaps and opportunities for action.
- Enhancement of diagnosis and management of migraine patients with a special interest in under-represented populations.
- Delivery of headache care in the primary care settings.
Funding Information
- Individual projects requesting up to $47,000 USD will be considered.
Duration
- Anticipated Project Start and End Dates: from January 2025 for a maximum duration of 12 Months.
Geographic Scope
Target Audience
- Healthcare professionals focused on diagnosis and management of headache and migraine (e.g., neurologist, family medicine doctors, primary health care providers, clinical pharmacists and specialty nurses).
Eligibility Criteria
- Applicant Eligibility Criteria:
- The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/ associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
- The Project Lead/PI must be an employee or contractor of the requesting organization.
For more information, visit Pfizer.
